oxazepam has been researched along with Kidney Diseases in 5 studies
Oxazepam: A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia.
oxazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a hydroxy group at position 3 and phenyl group at position 5.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The pharmacodynamic parameters from these models were not altered in renal dysfunction." | 1.30 | Single dose pharmacokinetics and pharmacodynamics of oxazepam in normal and renal dysfunction rats. ( Aiba, T; Hatanaka, T; Katayama, K; Koizumi, T; Srivastava, K, 1999) |
| "Oxazepam binding was unaffected by the presence of its glucuronide conjugates but was inhibited by fatty acids." | 1.27 | Protein binding of oxazepam and its glucuronide conjugates to human albumin. ( Boudinot, FD; Homon, CA; Jusko, WJ; Ruelius, HW, 1985) |
| "Oxazepam was undialyzable; since unbound oxazepam disposition kinetics are not altered, no dosage adjustment for patients is necessary." | 1.26 | Renal disease, age, and oxazepam kinetics. ( Chiang, ST; Koepke, HH; Murray, TG; Walker, BR, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vree, TB | 1 |
| Hekster, CA | 1 |
| van der Kleijn, E | 1 |
| Murray, TG | 1 |
| Chiang, ST | 1 |
| Koepke, HH | 1 |
| Walker, BR | 1 |
| Srivastava, K | 1 |
| Hatanaka, T | 1 |
| Aiba, T | 1 |
| Katayama, K | 1 |
| Koizumi, T | 1 |
| Kangas, L | 1 |
| Kanto, J | 1 |
| Forsström, J | 1 |
| Iisalo, E | 1 |
| Boudinot, FD | 1 |
| Homon, CA | 1 |
| Jusko, WJ | 1 |
| Ruelius, HW | 1 |
5 other studies available for oxazepam and Kidney Diseases
| Article | Year |
|---|---|
Significance of apparent half-lives of a metabolite with a higher elimination rate than its parent drug.
Topics: Diazepam; Glucuronates; Half-Life; Humans; Kidney Diseases; Metabolic Clearance Rate; Oxazepam; Phar | 1982 |
Renal disease, age, and oxazepam kinetics.
Topics: Adult; Age Factors; Aged; Humans; Kidney; Kidney Diseases; Kinetics; Middle Aged; Oxazepam; Renal Di | 1981 |
Single dose pharmacokinetics and pharmacodynamics of oxazepam in normal and renal dysfunction rats.
Topics: Animals; Anti-Anxiety Agents; Kidney Diseases; Male; Oxazepam; Rats; Rats, Wistar; Receptors, GABA-A | 1999 |
The protein binding of diazepam and N-demethyldiazepam in patients with poor renal function.
Topics: Adolescent; Adult; Aged; Creatinine; Diazepam; Female; Humans; Kidney Diseases; Male; Middle Aged; O | 1976 |
Protein binding of oxazepam and its glucuronide conjugates to human albumin.
Topics: Glucuronates; Humans; In Vitro Techniques; Kidney Diseases; Nitrophenols; Oxazepam; Protein Binding; | 1985 |